Pharmacogenetic considerations for non-Hodgkin's lymphoma therapy.

Espirito Santo, Ana; Medeiros, Rui

Espirito Santo, Ana; Medeiros, Rui.

Affiliation

Espirito Santo A; Servico de OncoHematologia, Portuguese Institute of Oncology , Porto , Portugal.

Expert Opin Drug Metab Toxicol ; 9(12): 1625-34, 2013 Dec.

Article in En | MEDLINE | ID: mdl-24053936

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Gene Expression Regulation, Neoplastic; Lymphoma, Non-Hodgkin/drug therapy; Lymphoma, Non-Hodgkin/genetics; Pharmacogenetics; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1/genetics; ATP Binding Cassette Transporter, Subfamily B, Member 1/metabolism; Drug Resistance, Neoplasm/genetics; Humans; Polymorphism, Single Nucleotide

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmacogenetics / Lymphoma, Non-Hodgkin / Antineoplastic Combined Chemotherapy Protocols / Gene Expression Regulation, Neoplastic Limits: Humans Language: En Journal: Expert Opin Drug Metab Toxicol Journal subject: METABOLISMO / TOXICOLOGIA Year: 2013 Document type: Article Affiliation country: Portugal Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google